Form 4 for AHR American Healthcare REIT, Inc.
Accepted 2025-03-26 00:00:00 ET · period of report 2025-03-25 · accession 0001433671-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-26 | 2025-03-25 | AHR | Prosky Danny | CEO, Pres, Dir | M - OptEx | — | +30.9K | 312.0K | +11% | — |
| D | 2025-03-26 | 2025-03-25 | AHR | Prosky Danny | CEO, Pres, Dir | A - Grant | $0.00 | +62.7K | 62.7K | New | $0 |
| D | 2025-03-26 | 2025-03-25 | AHR | Prosky Danny | CEO, Pres, Dir | M - OptEx | $0.00 | -30.9K | 61.8K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-25 | M | A | 30,885 | — | 312,044 | D | — | — | (F1) Each restricted stock unit ("RSU") converts into one share of the Issuer's common stock. |
| 2 | Derivative | Restricted Stock Unit | 2025-03-25 | A | A | 62,737 | $0.00 | 62,737 | D | — · — to — | 62,737 Common Stock | (F1) Each restricted stock unit ("RSU") converts into one share of the Issuer's common stock. (F4) On March 25, 2025, the Issuer awarded the Reporting Person 62,737 time-based RSUs. The RSUs will vest in three equal installments on March 25, 2026, 2027 and 2028 (subject to continuous employment through each vesting date). |
| 3 | Derivative | Restricted Stock Unit | 2025-03-25 | M | D | 30,885 | $0.00 | 61,771 | D | — · — to — | 30,885 Common Stock | (F1) Each restricted stock unit ("RSU") converts into one share of the Issuer's common stock. (F3) On March 25, 2024, the Issuer awarded the Reporting Person 92,656 time-based RSUs. The RSUs vest in three equal installments on March 25, 2025, 2026 and 2027 (subject to continuous employment through each vesting date). |